+49 170 62 47 020
Peter Bartenstein

Professor

Peter Bartenstein

Nuclear Medicine Radiologist

University Hospital of Munich

About the doctor

Profile

Scintigraphy of the thyroid gland, brain, bone marrow, testes, and liver, radioiodine therapy for benign and malignant thyroid disease, targeted radionuclide therapy for prostate cancer and neuroendocrine tumors, treatment of skeletal metastases with bone-seeking radiopharmaceuticals, selective Internal Radiation Therapy (SIRT) for liver malignancies, MIBG radiotherapy for neuroblastoma and pheochromocytoma/ paraganglioma

Work experience

40 years

Scientific activity

Author of over 700 peer-reviewed scientific publications in nuclear medicine, molecular imaging, and theranostics

Member of the core development team for novel radiopharmaceuticals used in PET/CT diagnostics and targeted radionuclide therapy

Leads translational research at University Hospital Munich to enable tumor-specific, precision diagnostic protocols

Cutting-edge developments at University Hospital Munich allow us to perform highly specific diagnostic procedures precisely tailored to each tumor type.

Peter Bartenstein

Data

Director, Department of Nuclear Medicine, Ludwig-Maximilians-Universität (LMU) Munich

Internationally recognized expert in theranostics, PSMA therapy, and neuroendocrine tumor management

Community

Executive Committee, German Consortium for Translational Cancer Research (DKTK)

German Society of Nuclear Medicine (Deutsche Gesellschaft für Nuklearmedizin, DGN)

European Association of Nuclear Medicine (EANM)

Society of Nuclear Medicine and Molecular Imaging (SNMMI)
 

Fill out an application